Imperial College London Featured PhD Programmes
Ulster University Featured PhD Programmes
Birkbeck, University of London Featured PhD Programmes
University of Portsmouth Featured PhD Programmes
University of Reading Featured PhD Programmes
"clinical" AND "trial"×
10 miles

Immunology (clinical trial) PhD Projects, Programs & Scholarships

We have 4 Immunology (clinical trial) PhD Projects, Programs & Scholarships

  • "clinical" AND "trial" ×
  • Immunology×
  • clear all
Order by 
Showing 1 to 4 of 4
  A personalised medicine approach to the treatment of low dose interleukin-2 in amyotrophic lateral sclerosis: predicting patients’ response through blood transcriptomics
  Dr J Kirby, Dr D Wang
Application Deadline: 29 January 2020

Funding Type

PhD Type

Background. The Horizon 2020 funded project, MIROCALS, is a clinical trial of low-dose interleukin-2 (IL-2) in patients with amyotrophic lateral sclerosis (ALS), an adult onset neurodegenerative disorder.
  Repurposing drugs to enhance the activity of oncolytic viruses in platinum-resistant ovarian cancer
  Dr M Lockley, Dr S Martin
Application Deadline: 7 February 2020

Funding Type

PhD Type

We are seeking applications for a fully-funded PhD fellowship for clinically qualified candidates to commence in October 2020. The Fellowship will be supervised by Dr.
  Characterising B cells in Rheumatoid Arthritis: Their role in susceptibility, pathogenesis, and treatment response
  Dr S Viatte, Dr Gemma Radley, Prof A Barton
Applications accepted all year round

Funding Type

PhD Type

Background. Rheumatoid arthritis (RA) is a chronic inflammatory autoimmune disease that primarily affects the joints. In the UK, some patients who fail to respond to methotrexate (MTX) and TNF inhibitors (TNFi) are started on rituximab, and 20% will experience a favourable clinical response.
  Immune phenotyping of refractory rheumatoid arthritis disease
  Prof Maya Buch, Dr S Viatte
Applications accepted all year round

Funding Type

PhD Type

Treatment of rheumatoid arthritis (RA) has been transformed with the introduction of targeted therapies twenty years ago (comprising biologic disease modifying anti-rheumatic drugs, bDMARDS; and the more recent small molecule JAK inhibitors).
Show 10 15 30 per page
  • 1


FindAPhD. Copyright 2005-2020
All rights reserved.